<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK1294" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK1294/" /><meta name="ncbi_pagename" content="Wilms Tumor Predisposition - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Wilms Tumor Predisposition - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Wilms Tumor Predisposition" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2016/10/20" /><meta name="citation_author" content="Jeffrey S Dome" /><meta name="citation_author" content="Vicki Huff" /><meta name="citation_pmid" content="20301471" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK1294/" /><meta name="citation_keywords" content="Bloom syndrome protein" /><meta name="citation_keywords" content="Breast cancer type 2 susceptibility protein" /><meta name="citation_keywords" content="Cellular tumor antigen p53" /><meta name="citation_keywords" content="Cyclin-dependent kinase inhibitor 1C" /><meta name="citation_keywords" content="DIS3-like exonuclease 2" /><meta name="citation_keywords" content="Endoribonuclease Dicer" /><meta name="citation_keywords" content="Glypican-3" /><meta name="citation_keywords" content="Glypican-4" /><meta name="citation_keywords" content="Histone-lysine N-methyltransferase, H3 lysine-36 and H4 lysine-20 specific" /><meta name="citation_keywords" content="Insulin-like growth factor II" /><meta name="citation_keywords" content="Neurofibromin" /><meta name="citation_keywords" content="Parafibromin" /><meta name="citation_keywords" content="Wilms tumor protein" /><meta name="citation_keywords" content="BLM" /><meta name="citation_keywords" content="BRCA2" /><meta name="citation_keywords" content="CDC73" /><meta name="citation_keywords" content="CDKN1C" /><meta name="citation_keywords" content="DICER1" /><meta name="citation_keywords" content="DIS3L2" /><meta name="citation_keywords" content="GPC3" /><meta name="citation_keywords" content="GPC4" /><meta name="citation_keywords" content="H19" /><meta name="citation_keywords" content="IGF2" /><meta name="citation_keywords" content="NF1" /><meta name="citation_keywords" content="NSD1" /><meta name="citation_keywords" content="TP53" /><meta name="citation_keywords" content="WT1" /><meta name="citation_keywords" content="Wilms Tumor Predisposition" /><meta name="citation_keywords" content="Overview" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Wilms Tumor Predisposition" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Jeffrey S Dome" /><meta name="DC.Contributor" content="Vicki Huff" /><meta name="DC.Date" content="2016/10/20" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK1294/" /><meta name="description" content="This GeneReview is intended to help clinicians determine if a genetic basis can be identified in an individual with Wilms tumor in order to provide families with natural history and recurrence risk information." /><meta name="og:title" content="Wilms Tumor Predisposition" /><meta name="og:type" content="book" /><meta name="og:description" content="This GeneReview is intended to help clinicians determine if a genetic basis can be identified in an individual with Wilms tumor in order to provide families with natural history and recurrence risk information." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK1294/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/wilms-ov/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK1294/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE898649E04102010000000000E20061.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK1294_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK1294_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/williams/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/wilson/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK1294_"><span class="title" itemprop="name">Wilms Tumor Predisposition</span></h1><p class="contrib-group"><span itemprop="author">Jeffrey S Dome</span>, MD, PhD and <span itemprop="author">Vicki Huff</span>, PhD.</p><a data-jig="ncbitoggler" href="#__NBK1294_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK1294_ai__"><div class="contrib half_rhythm"><span itemprop="author">Jeffrey S Dome</span>, MD, PhD<div class="affiliation small">Children&#x02019;s National Health System<br />Washington, DC<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="gro.lanoitansnerdlihc@emodj" class="oemail">gro.lanoitansnerdlihc@emodj</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Vicki Huff</span>, PhD<div class="affiliation small">Department of Genetics<br />University of Texas MD Anderson Cancer Center<br />Houston, Texas<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="gro.nosrednadm@ffuhv" class="oemail">gro.nosrednadm@ffuhv</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">December 19, 2003</span>; Last Update: <span itemprop="dateModified">October 20, 2016</span>.</p><p><em>Estimated reading time: 19 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="wilms-ov.Summary" itemprop="description"><h2 id="_wilms-ov_Summary_">Summary</h2><div><h4 class="inline">Purpose.</h4><p>This <i>GeneReview</i> is intended to help clinicians determine if a genetic basis can be identified in an individual with Wilms tumor in order to provide families with natural history and <a class="def" href="/books/n/gene/glossary/def-item/recurrence-risk/">recurrence risk</a> information.</p></div><div><h4 class="inline">Goal 1.</h4><p>Briefly describe the clinical characteristics of Wilms tumor.</p></div><div><h4 class="inline">Goal 2.</h4><p>Review the mechanisms of predisposition to Wilms tumor.</p></div><div><h4 class="inline">Goal 3.</h4><p>Provide an evaluation strategy to:</p><ul><li class="half_rhythm"><div>Determine if a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with Wilms tumor has a predisposition to Wilms tumor;</div></li><li class="half_rhythm"><div>Identify the genetic or epigenetic mechanism for Wilms tumor; and</div></li><li class="half_rhythm"><div>Determine risks for additional medical complications.</div></li></ul></div><div><h4 class="inline">Goal 4.</h4><p>Discuss <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> issues including <a class="def" href="/books/n/gene/glossary/def-item/mode-of-inheritance/">mode of inheritance</a>, <a class="def" href="/books/n/gene/glossary/def-item/recurrence-risk/">recurrence risk</a>, and evaluation of relatives at risk based on the underlying genetic mechanism.</p></div><div><h4 class="inline">Goal 5.</h4><p>Discuss management (e.g., tumor screening) recommendations for individuals with a genetic predisposition to Wilms tumor.</p></div></div><div id="wilms-ov.Clinical_Characteristics_of_Wil"><h2 id="_wilms-ov_Clinical_Characteristics_of_Wil_">Clinical Characteristics of Wilms Tumor</h2><p>Wilms tumor (nephroblastoma), an embryonal malignancy of the kidney, is the most common renal tumor of childhood. It usually presents as an abdominal mass in an otherwise apparently healthy child. Abdominal pain, fever, anemia, hematuria, and hypertension are seen in 25%-30% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> children.</p><p>Approximately 5%-10% of individuals with Wilms tumor have bilateral or multicentric tumors. The prevalence of bilateral involvement is higher in individuals with a predisposition to Wilms tumor than in those without a genetic predisposition (see <a href="#wilms-ov.Mechanisms_of_Predisposition_to">Mechanisms of Predisposition to Wilms Tumor</a>).</p><p>A definitive diagnosis of Wilms tumor can be made only on histologic assessment of the tumor.</p><p>Nephrogenic rests, benign foci of embryonal kidney cells that persist abnormally into postnatal life, are considered to be Wilms tumor precursors. Pathogenic variants may predispose to nephrogenic rests. Additional pathogenic variants transform nephrogenic rests into a Wilms tumor [<a class="bk_pop" href="#wilms-ov.REF.dome.2002.5">Dome &#x00026; Coppes 2002</a>].</p></div><div id="wilms-ov.Mechanisms_of_Predisposition_to"><h2 id="_wilms-ov_Mechanisms_of_Predisposition_to_">Mechanisms of Predisposition to Wilms Tumor</h2><p>In 10%-15% of individuals with Wilms tumor, the cause is considered to be a <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> or an epigenetic alteration occurring early during embryogenesis (see <a href="#wilms-ov.11p15_5Related_Wilms_Tumor">11p15-Related Wilms Tumor</a>). These may or may not be associated with a known <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> malformation syndrome or hereditary cancer syndrome.</p><p>Approximately 1%-2% of individuals with Wilms tumor have at least one relative also diagnosed with Wilms tumor (<a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> Wilms tumor); however, while <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> variants that are likely pathogenic have been identified in some families, they are still not known for the majority of individuals.</p><p>The most commonly reported <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> genetic and epigenetic variants in individuals with Wilms tumor involve <i>WT1</i> and the 11p15.5 <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a>. A growing number of variants in other genes have been reported. In some cases, the estimated of risk of Wilms tumor with these variants is high, but the variant or syndrome is so rare in the general population that only a handful of individuals with Wilms tumor have ever been reported. For example, among eight individuals reported with mosaic variegated <a class="def" href="/books/n/gene/glossary/def-item/aneuploidy/">aneuploidy</a> and germline monoallelic <i>BUB1B</i> variants, seven (87.5%) had Wilms tumor. However, only about ten individuals with mosaic variegated aneuploidy and Wilms tumor have ever been reported. The following sections describe <a href="#wilms-ov.WT1Related_Wilms_Tumor"><i>WT1-</i></a> and <a href="#wilms-ov.11p15_5Related_Wilms_Tumor">11p15-related</a> Wilms tumor in depth. <a class="figpopup" href="/books/NBK1294/table/wilms-ov.T.less_common_causes_of_wilms_t/?report=objectonly" target="object" rid-figpopup="figwilmsovTlesscommoncausesofwilmst" rid-ob="figobwilmsovTlesscommoncausesofwilmst">Table 1</a> summarizes other variants and syndromes that have been associated with Wilms tumor.</p><div id="wilms-ov.WT1Related_Wilms_Tumor"><h3><i>WT1</i>-Related Wilms Tumor</h3><p>Heterozygous <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> <i>WT1</i> pathogenic variants have been identified in some individuals with Wilms tumor without <a class="def" href="/books/n/gene/glossary/def-item/syndromic/">syndromic</a> features, in some families with Wilms tumor, in individuals with WAGR syndrome (<i>W</i>ilms tumor, <i>a</i>niridia, <i>g</i>enital anomalies, <i>r</i>etardation), Denys-Drash syndrome (DDS), and Frasier syndrome, and in individuals with genitourinary anomalies without renal failure.</p><div id="wilms-ov.Wilms_Tumor_Without_Syndromic_F"><h4>Wilms Tumor Without Syndromic Features</h4><p>Germline <i>WT1</i> pathogenic variants have a greater effect on sex determination and genital tract development in males; therefore, females with a <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> <i>WT1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> are less likely to exhibit genitourinary anomalies. Individuals with germline <i>WT1</i> pathogenic variants are more likely to have bilateral or multicentric tumors and to develop tumors at an early age [<a class="bk_pop" href="#wilms-ov.REF.royerpokora.2004.249">Royer-Pokora et al 2004</a>]. In the absence of genitourinary anomalies, renal mesangial sclerosis, or bilateral tumors, the likelihood that a child with Wilms tumor has a germline <i>WT1</i> pathogenic variant is low, with reported frequencies of 0%-5% [<a class="bk_pop" href="#wilms-ov.REF.huff.1998.260">Huff 1998</a>, <a class="bk_pop" href="#wilms-ov.REF.little.2004.4140">Little et al 2004</a>, <a class="bk_pop" href="#wilms-ov.REF.segers.2012.3249">Segers et al 2012</a>].</p></div><div id="wilms-ov.Familial_Wilms_Tumor"><h4>Familial Wilms Tumor</h4><p>Although pathogenic variants in <i>WT1</i> are not implicated in most families with Wilms tumor predisposition, a small number of families have <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> <i>WT1</i> pathogenic variants [<a class="bk_pop" href="#wilms-ov.REF.grundy.1988.374">Grundy et al 1988</a>, <a class="bk_pop" href="#wilms-ov.REF.huff.1988.377">Huff et al 1988</a>, <a class="bk_pop" href="#wilms-ov.REF.diller.1998.3634">Diller et al 1998</a>, <a class="bk_pop" href="#wilms-ov.REF.huff.1998.260">Huff 1998</a>].</p></div><div id="wilms-ov.WAGR_Syndrome"><h4>WAGR Syndrome</h4><p><a href="/books/n/gene/aniridia/">WAGR syndrome</a> (<i>W</i>ilms tumor, <i>a</i>niridia, <i>g</i>enital anomalies, <i>r</i>etardation) is characterized by Wilms tumor, aniridia, hemihypertrophy, genitourinary abnormalities, ambiguous genitalia, gonadoblastoma, and intellectual disability.</p><p><b>Genetic alteration.</b> A <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/contiguous-gene-deletion/">contiguous gene deletion</a> at 11p13 that includes both <i>WT1</i> and <i>PAX6</i> is causative. Aniridia arises from deletion of <i>PAX6</i>, which lies within approximately 0.6 Mb of <i>WT1</i>.</p><p><b>Risk for Wilms tumor.</b> The risk for Wilms tumor in individuals with WAGR syndrome is estimated at between 45% and 60% [<a class="bk_pop" href="#wilms-ov.REF.muto.2002.285">Muto et al 2002</a>, <a class="bk_pop" href="#wilms-ov.REF.fischbach.2005.984">Fischbach et al 2005</a>]. The risk for Wilms tumor in <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> cases (i.e., a single occurrence of aniridia in a family) is 40%-50% if the individual has an 11p13 <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> that includes <i>WT1</i>. Wilms tumor has not been reported in two large series of individuals with aniridia and <i>PAX6</i> alterations if <i>WT1</i> deletion is not detected by <a class="def" href="/books/n/gene/glossary/def-item/fish/">FISH</a> [<a class="bk_pop" href="#wilms-ov.REF.gr_nskov.2001.11">Gr&#x000f8;nskov et al 2001</a>, <a class="bk_pop" href="#wilms-ov.REF.muto.2002.285">Muto et al 2002</a>].</p><p>Individuals with WAGR syndrome have an earlier age of Wilms tumor diagnosis and more frequent occurrence of bilateral disease than other individuals with Wilms tumor. Among individuals with Wilms tumor and WAGR syndrome, 90% develop Wilms tumor by age four years and 98% by age seven years [<a class="bk_pop" href="#wilms-ov.REF.beckwith.1998b.268">Beckwith 1998b</a>]. Of note, they also have a high incidence of intralobar nephrogenic rests and their tumors invariably exhibit a favorable histology. Individuals with WAGR syndrome have short-term survival comparable to persons who do not have WAGR syndrome [<a class="bk_pop" href="#wilms-ov.REF.breslow.2003.4579">Breslow et al 2003</a>]. However, individuals with a <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> <i>WT1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> are more likely to have a stromal histology of Wilms tumor called fetal rhabdomyomatous nephroblastoma [<a class="bk_pop" href="#wilms-ov.REF.royerpokora.2004.249">Royer-Pokora et al 2004</a>]. This histologic subtype has clinical implications because it may not shrink and sometimes grows in response to chemotherapy, which impedes surgical resection.</p><p><b>Other findings.</b> Individuals with WAGR syndrome often develop end-stage renal disease (ESRD) around adolescence, resulting in declining survival. In studies employing the National Wilms Tumor Studies (NWTS) patient population, 34%-40% of individuals with WAGR syndrome who survived a Wilms tumor subsequently developed ESRD. A 48% (&#x000b1;17%) survival rate at age 27 years from diagnosis of Wilms tumor was estimated for this group [<a class="bk_pop" href="#wilms-ov.REF.breslow.2000.4030">Breslow et al 2000</a>, <a class="bk_pop" href="#wilms-ov.REF.breslow.2003.4579">Breslow et al 2003</a>, <a class="bk_pop" href="#wilms-ov.REF.breslow.2005.1972">Breslow et al 2005</a>].</p></div><div id="wilms-ov.DenysDrash_Syndrome"><h4>Denys-Drash Syndrome</h4><p>Denys-Drash syndrome (DDS) is characterized by diffuse mesangial sclerosis leading to early-onset renal failure, intersex disorders that can range from ambiguous to normal-appearing female in both XY &#x00026; XX individuals, and a high risk of Wilms tumor.</p><p><b>Genetic alteration.</b> The majority of individuals with DDS have a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>WT1</i> <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 8 or 9 [<a class="bk_pop" href="#wilms-ov.REF.royerpokora.2004.249">Royer-Pokora et al 2004</a>]. While other types of <i>WT1</i> pathogenic variants in a small number of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals are reported in the literature, they are often in individuals diagnosed as having DDS in the absence of renal failure [<a class="bk_pop" href="#wilms-ov.REF.royerpokora.2004.249">Royer-Pokora et al 2004</a>].</p><p><b>Risk for Wilms tumor.</b> In one large study, 74% of children with DDS developed Wilms tumor. The risk for Wilms tumor in individuals with DDS is likely higher than reported, as children with DDS often undergo kidney transplants or die of end-stage renal failure before the (potential) development of tumors [<a class="bk_pop" href="#wilms-ov.REF.eddy.1985.584">Eddy &#x00026; Mauer 1985</a>, <a class="bk_pop" href="#wilms-ov.REF.mueller.1994.471">Mueller 1994</a>].</p><p><b>Other findings.</b> Renal failure in individuals with DDS tends to be earlier onset. The NWTS reported that the cumulative incidence of renal failure in those with DDS, 20 years after Wilms tumor diagnosis, was 74% [<a class="bk_pop" href="#wilms-ov.REF.breslow.2005.1972">Breslow et al 2005</a>].</p></div><div id="wilms-ov.Frasier_Syndrome"><h4>Frasier Syndrome</h4><p>Frasier syndrome (FS) is characterized by undermasculinized external genitalia that can range from ambiguous to normal-appearing female in an individual with a 46,XY <a class="def" href="/books/n/gene/glossary/def-item/karyotype/">karyotype</a>, focal segmental glomerulosclerosis, and gonadoblastoma. While originally considered distinct from DDS, the observation of individuals displaying phenotypes classically ascribed to both DDS and FS, including a child with a <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> <i>WT1</i> <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> who was diagnosed with both Wilms tumor and gonadoblastoma, has led to the suggestion that DDS and FS represent two ends of a phenotypic spectrum [<a class="bk_pop" href="#wilms-ov.REF.koziell.2000.519">Koziell et al 2000</a>, <a class="bk_pop" href="#wilms-ov.REF.finken.2015.211">Finken et al 2015</a>].</p><p><b>Genetic alteration.</b> Heterozygous single-nucleotide variants in the <i>WT1</i> <a class="def" href="/books/n/gene/glossary/def-item/intron/">intron</a> 9 donor <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> are the predominant type of alteration observed in individuals diagnosed with FS [<a class="bk_pop" href="#wilms-ov.REF.barbaux.1997.467">Barbaux et al 1997</a>].</p><p><b>Risk for Wilms tumor.</b> Wilms tumors are not typically observed in individuals with <i>WT1</i> <a class="def" href="/books/n/gene/glossary/def-item/intron/">intron</a> 9 variants. However, the suggestion that DDS and FS represent a single syndrome of variable phenotypes implies that individuals diagnosed with FS may be at risk for Wilms tumor.</p></div><div id="wilms-ov.Genitourinary_GU_Anomalies_With"><h4>Genitourinary (GU) Anomalies Without Renal Failure</h4><p>Some individuals with <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> <i>WT1</i> alterations have GU anomalies and Wilms tumor, but do not have early renal failure. A summary of 117 individuals with germline <i>WT1</i> alterations who were ascertained via a diagnosis of Wilms tumor or Wilms tumor-related phenotypes indicated that a third displayed no evidence of renal failure at the time of Wilms tumor diagnosis [<a class="bk_pop" href="#wilms-ov.REF.royerpokora.2004.249">Royer-Pokora et al 2004</a>]. However, as renal failure can develop at later ages [<a class="bk_pop" href="#wilms-ov.REF.breslow.2000.4030">Breslow et al 2000</a>], the proportion of individuals carrying a <i>WT1</i> germline alteration who do not ultimately develop renal failure is expected to be less.</p><p><b>Genetic alteration.</b> These findings are predominantly associated with <i>WT1</i> deletions and <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a> and frameshift variants.</p></div></div><div id="wilms-ov.11p15_5Related_Wilms_Tumor"><h3>11p15.5-Related Wilms Tumor</h3><div id="wilms-ov.BeckwithWiedemann_Syndrome"><h4>Beckwith-Wiedemann Syndrome</h4><p><a href="/books/n/gene/bws/">Beckwith-Wiedemann syndrome</a> (BWS) is characterized by macrosomia, macroglossia, hemihyperplasia, visceromegaly, embryonal tumors (e.g., Wilms tumor, hepatoblastoma, neuroblastoma, and rhabdomyosarcoma), omphalocele, neonatal hypoglycemia, ear creases/pits, adrenocortical cytomegaly, and renal abnormalities.</p><p><b>Genetic alteration.</b> BWS is associated with abnormal regulation of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> transcription in an <a class="def" href="/books/n/gene/glossary/def-item/imprinted/">imprinted</a> <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> on <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> 11p15.5 (see <a href="/books/n/gene/bws/">Beckwith-Wiedemann Syndrome</a>).</p><p><b>Risk for Wilms tumor.</b> Wilms tumor occurs in approximately 7% of children with BWS. Uniparental disomy of 11p15.5 or gain of <a class="def" href="/books/n/gene/glossary/def-item/methylation/">methylation</a> at <a class="def" href="/books/n/gene/glossary/def-item/imprinting/">imprinting</a> center 1 (IC1) is associated with the highest risk for Wilms tumor in BWS; a quarter of children with these alterations developed Wilms tumor. Among individuals with BWS and Wilms tumor, 81% develop the tumor by age five years and 93% develop the tumor by age eight years [<a class="bk_pop" href="#wilms-ov.REF.beckwith.1998a.377">Beckwith 1998a</a>, <a class="bk_pop" href="#wilms-ov.REF.rump.2005.95">Rump et al 2005</a>, <a class="bk_pop" href="#wilms-ov.REF.weksberg.2010.8">Weksberg et al 2010</a>].</p></div><div id="wilms-ov.Wilms_Tumor_Without_Syndrome_Fe"><h4>Wilms Tumor Without Syndrome Features</h4><p>Wilms tumor without syndrome features can be associated with alterations of <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> 11p15.5 including gain of <a class="def" href="/books/n/gene/glossary/def-item/methylation/">methylation</a> at IC1, paternal <a class="def" href="/books/n/gene/glossary/def-item/uniparental-disomy/">uniparental disomy</a> of 11p15.5, and <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> abnormalities including microdeletion and microinsertion [<a class="bk_pop" href="#wilms-ov.REF.scott.2008.1329">Scott et al 2008</a>].</p></div></div><div id="wilms-ov.Less_Common_Causes_of_Wilms_Tum"><h3>Less Common Causes of Wilms Tumor Predisposition</h3><div id="wilms-ov.T.less_common_causes_of_wilms_t" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Less Common Causes of Wilms Tumor Predisposition.</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1294/table/wilms-ov.T.less_common_causes_of_wilms_t/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__wilms-ov.T.less_common_causes_of_wilms_t_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_wilms-ov.T.less_common_causes_of_wilms_t_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene</th><th id="hd_h_wilms-ov.T.less_common_causes_of_wilms_t_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Syndrome</th><th id="hd_h_wilms-ov.T.less_common_causes_of_wilms_t_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Estimated Wilms Tumor Risk</th><th id="hd_h_wilms-ov.T.less_common_causes_of_wilms_t_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">References</th></tr></thead><tbody><tr><td headers="hd_h_wilms-ov.T.less_common_causes_of_wilms_t_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>BLM</i></td><td headers="hd_h_wilms-ov.T.less_common_causes_of_wilms_t_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/bloom/">Bloom syndrome</a></td><td headers="hd_h_wilms-ov.T.less_common_causes_of_wilms_t_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0223c;3%</td><td headers="hd_h_wilms-ov.T.less_common_causes_of_wilms_t_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#wilms-ov.REF.moreira.2013">Moreira et al [2013]</a></td></tr><tr><td headers="hd_h_wilms-ov.T.less_common_causes_of_wilms_t_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>BRCA2</i></td><td headers="hd_h_wilms-ov.T.less_common_causes_of_wilms_t_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/fa/">Fanconi anemia</a> (FA-D1)</td><td headers="hd_h_wilms-ov.T.less_common_causes_of_wilms_t_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0223c;20%</td><td headers="hd_h_wilms-ov.T.less_common_causes_of_wilms_t_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#wilms-ov.REF.reid.2005.147">Reid et al [2005]</a>, <a class="bk_pop" href="#wilms-ov.REF.scott.2006.995">Scott et al [2006]</a></td></tr><tr><td headers="hd_h_wilms-ov.T.less_common_causes_of_wilms_t_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>BUB1B</i></td><td headers="hd_h_wilms-ov.T.less_common_causes_of_wilms_t_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Mosaic variegated <a class="def" href="/books/n/gene/glossary/def-item/aneuploidy/">aneuploidy</a> (MVA) (OMIM <a href="http://omim.org/entry/257300" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">257300</a>)</td><td headers="hd_h_wilms-ov.T.less_common_causes_of_wilms_t_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0223c;25% overall in MVA<br />&#x0003e;85% in individuals w/<i>BUB1B</i> pathogenic variants</td><td headers="hd_h_wilms-ov.T.less_common_causes_of_wilms_t_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#wilms-ov.REF.callier.2005.204">Callier et al [2005]</a>, <a class="bk_pop" href="#wilms-ov.REF.garc_acastillo.2008.1687">Garc&#x000ed;a-Castillo et al [2008]</a></td></tr><tr><td headers="hd_h_wilms-ov.T.less_common_causes_of_wilms_t_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>CDC73</i></td><td headers="hd_h_wilms-ov.T.less_common_causes_of_wilms_t_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Hyperparathyroid-jaw tumor syndrome (OMIM <a href="http://omim.org/entry/145001" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">145001</a>)</td><td headers="hd_h_wilms-ov.T.less_common_causes_of_wilms_t_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0223c;3%</td><td headers="hd_h_wilms-ov.T.less_common_causes_of_wilms_t_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#wilms-ov.REF.kakinuma.1994.123">Kakinuma et al [1994]</a>, <a class="bk_pop" href="#wilms-ov.REF.szab_.1995.944">Szab&#x000f3; et al [1995]</a></td></tr><tr><td headers="hd_h_wilms-ov.T.less_common_causes_of_wilms_t_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>CTR9</i></td><td headers="hd_h_wilms-ov.T.less_common_causes_of_wilms_t_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Familial Wilms tumor</td><td headers="hd_h_wilms-ov.T.less_common_causes_of_wilms_t_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">3 families reported<br />6/9 individuals w/a <i>CTR9</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in these families had Wilms tumor.</td><td headers="hd_h_wilms-ov.T.less_common_causes_of_wilms_t_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#wilms-ov.REF.hanks.2014.4398">Hanks et al [2014]</a></td></tr><tr><td headers="hd_h_wilms-ov.T.less_common_causes_of_wilms_t_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>DICER1</i></td><td headers="hd_h_wilms-ov.T.less_common_causes_of_wilms_t_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/pp-blastoma/"><i>DICER1</i>-related disorders</a></td><td headers="hd_h_wilms-ov.T.less_common_causes_of_wilms_t_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Low risk w/most <i>DICER1</i> variants<br />Higher risk (2/11; 18%) in individuals w/Gly803Arg variant</td><td headers="hd_h_wilms-ov.T.less_common_causes_of_wilms_t_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#wilms-ov.REF.foulkes.2011.1381">Foulkes et al [2011]</a>, <a class="bk_pop" href="#wilms-ov.REF.palculict.2016.385">Palculict et al [2016]</a></td></tr><tr><td headers="hd_h_wilms-ov.T.less_common_causes_of_wilms_t_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>DIS3L2</i></td><td headers="hd_h_wilms-ov.T.less_common_causes_of_wilms_t_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Perlman syndrome (OMIM <a href="http://omim.org/entry/267000" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">267000</a>)</td><td headers="hd_h_wilms-ov.T.less_common_causes_of_wilms_t_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0223c;30%</td><td headers="hd_h_wilms-ov.T.less_common_causes_of_wilms_t_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#wilms-ov.REF.scott.2006.995">Scott et al [2006]</a>, <a class="bk_pop" href="#wilms-ov.REF.astuti.2012.277">Astuti et al [2012]</a></td></tr><tr><td headers="hd_h_wilms-ov.T.less_common_causes_of_wilms_t_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>GPC3, GPC4</i></td><td headers="hd_h_wilms-ov.T.less_common_causes_of_wilms_t_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/sgbs/">Simpson-Golabi-Behmel type 1</a></td><td headers="hd_h_wilms-ov.T.less_common_causes_of_wilms_t_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">4%-9%</td><td headers="hd_h_wilms-ov.T.less_common_causes_of_wilms_t_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#wilms-ov.REF.lapunzina.2005.53">Lapunzina [2005]</a>, <a class="bk_pop" href="#wilms-ov.REF.scott.2006.995">Scott et al [2006]</a></td></tr><tr><td headers="hd_h_wilms-ov.T.less_common_causes_of_wilms_t_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PALB2</i></td><td headers="hd_h_wilms-ov.T.less_common_causes_of_wilms_t_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/fa/">Fanconi anemia</a> (FA-N)</td><td headers="hd_h_wilms-ov.T.less_common_causes_of_wilms_t_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0223c;40%</td><td headers="hd_h_wilms-ov.T.less_common_causes_of_wilms_t_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#wilms-ov.REF.reid.2007.162">Reid et al [2007]</a></td></tr><tr><td headers="hd_h_wilms-ov.T.less_common_causes_of_wilms_t_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PIK3CA</i></td><td headers="hd_h_wilms-ov.T.less_common_causes_of_wilms_t_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/pik3ca-overgrowth/"><i>PIK3CA</i>-related segmental overgrowth</a></td><td headers="hd_h_wilms-ov.T.less_common_causes_of_wilms_t_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1%-2%</td><td headers="hd_h_wilms-ov.T.less_common_causes_of_wilms_t_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#wilms-ov.REF.gripp.2016.2559">Gripp et al [2016]</a></td></tr><tr><td headers="hd_h_wilms-ov.T.less_common_causes_of_wilms_t_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>REST</i></td><td headers="hd_h_wilms-ov.T.less_common_causes_of_wilms_t_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Familial Wilms tumor (OMIM <a href="http://omim.org/entry/616806" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">616806</a>)<br />Additional clinical features reported in several <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals</td><td headers="hd_h_wilms-ov.T.less_common_causes_of_wilms_t_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">4 families reported<br />7/14 individuals w/a <i>REST</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in these families had Wilms tumor.<br />9 nonfamilial Wilms tumor</td><td headers="hd_h_wilms-ov.T.less_common_causes_of_wilms_t_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#wilms-ov.REF.mahamdallie.2015.1471">Mahamdallie et al [2015]</a></td></tr><tr><td headers="hd_h_wilms-ov.T.less_common_causes_of_wilms_t_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>TP53</i></td><td headers="hd_h_wilms-ov.T.less_common_causes_of_wilms_t_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/li-fraumeni/">Li-Fraumeni syndrome</a></td><td headers="hd_h_wilms-ov.T.less_common_causes_of_wilms_t_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Low, but several cases reported</td><td headers="hd_h_wilms-ov.T.less_common_causes_of_wilms_t_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#wilms-ov.REF.birch.2001.4621">Birch et al [2001]</a>, <a class="bk_pop" href="#wilms-ov.REF.schlegelberger.2015.1481">Schlegelberger et al [2015]</a></td></tr><tr><td headers="hd_h_wilms-ov.T.less_common_causes_of_wilms_t_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>TRIM37</i></td><td headers="hd_h_wilms-ov.T.less_common_causes_of_wilms_t_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Mulibrey nanism (OMIM <a href="http://omim.org/entry/253250" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">253250</a>)</td><td headers="hd_h_wilms-ov.T.less_common_causes_of_wilms_t_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">6%</td><td headers="hd_h_wilms-ov.T.less_common_causes_of_wilms_t_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#wilms-ov.REF.scott.2006.995">Scott et al [2006]</a>, <a class="bk_pop" href="#wilms-ov.REF.karlberg.2009.570">Karlberg et al [2009]</a></td></tr><tr><td headers="hd_h_wilms-ov.T.less_common_causes_of_wilms_t_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown</td><td headers="hd_h_wilms-ov.T.less_common_causes_of_wilms_t_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Trisomy 18</td><td headers="hd_h_wilms-ov.T.less_common_causes_of_wilms_t_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">12 individuals reported w/Wilms tumor&#x000a0;<sup>1</sup></td><td headers="hd_h_wilms-ov.T.less_common_causes_of_wilms_t_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#wilms-ov.REF.scott.2006.995">Scott et al [2006]</a>, <a class="bk_pop" href="#wilms-ov.REF.shanske.2006.966">Shanske [2006]</a></td></tr><tr><td headers="hd_h_wilms-ov.T.less_common_causes_of_wilms_t_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown</td><td headers="hd_h_wilms-ov.T.less_common_causes_of_wilms_t_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Trisomy 13</td><td headers="hd_h_wilms-ov.T.less_common_causes_of_wilms_t_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2 individuals reported w/Wilms tumor&#x000a0;<sup>1</sup></td><td headers="hd_h_wilms-ov.T.less_common_causes_of_wilms_t_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#wilms-ov.REF.olson.1995.305">Olson et al [1995]</a>, <a class="bk_pop" href="#wilms-ov.REF.sweeney.2000.171">Sweeney &#x00026; Pelegano [2000]</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="wilms-ov.TF.1.1"><p class="no_margin">Given early mortality, the risk for Wilms tumor may be higher than indicated by the number of individuals reported.</p></div></dd></dl></div></div></div></div></div><div id="wilms-ov.Evaluation_Strategy"><h2 id="_wilms-ov_Evaluation_Strategy_">Evaluation Strategy</h2><p>The following approach can be used to determine if a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with Wilms tumor has a predisposition to Wilms tumor, to identify the genetic or epigenetic mechanism for Wilms tumor, and to determine risks for additional medical complications. Establishing the genetic mechanism for a predisposition to Wilms tumor involves a medical history, family history, physical examination, and <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>.</p><div id="wilms-ov.Clinical_Findings"><h3>Clinical Findings</h3><p>Physical features suggestive of a <i>WT1</i>-related Wilms tumor include aniridia, genitourinary anomalies (including ambiguous genitalia), renal insufficiency or failure, and intellectual disability. Features suggestive of <a href="/books/n/gene/bws/">Beckwith-Wiedemann syndrome</a> (BWS) include macrosomia, ear creases/pits, macroglossia, omphalocele, visceromegaly, other embryonal tumors (e.g., hepatoblastoma, neuroblastoma, and rhabdomyosarcoma), hemihyperplasia, adrenocortical cytomegaly, and renal abnormalities. Physical features may also be observed in other syndromes that predispose to Wilms tumor (see <a class="figpopup" href="/books/NBK1294/table/wilms-ov.T.less_common_causes_of_wilms_t/?report=objectonly" target="object" rid-figpopup="figwilmsovTlesscommoncausesofwilmst" rid-ob="figobwilmsovTlesscommoncausesofwilmst">Table 1</a>).</p><p>In addition to physical features, radiologic or histologic findings may indicate the possibility of genetic predisposition to Wilms tumor. The presence of bilateral or multifocal Wilms tumor is suggestive of a genetic predisposition. Nephrogenic rests may provide corroborative evidence for Wilms tumor predisposition, although more than 25% of individuals with unilateral, seemingly <a class="def" href="/books/n/gene/glossary/def-item/sporadic/">sporadic</a> Wilms tumor have nephrogenic rests in kidney tissue that is free of tumors [<a class="bk_pop" href="#wilms-ov.REF.beckwith.1993.158">Beckwith 1993</a>]. Hence, the presence of nephrogenic rests in the absence of other features does not warrant a molecular genetic evaluation. The histologic finding of fetal rhabdomyomatous nephroblastoma should raise awareness of <i>WT1</i> variants, which may be <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> or restricted to the tumor tissue.</p></div><div id="wilms-ov.Family_History"><h3>Family History</h3><p>Given the rarity of Wilms tumor in the population, the existence of a relative with Wilms tumor is suggestive of a genetic predisposition.</p></div><div id="wilms-ov.Molecular_Genetic_Testing"><h3>Molecular Genetic Testing</h3><p>Molecular genetic testing should be considered in individuals with Wilms tumor who have physical, radiologic, or histologic features suggestive of a genetic predisposition. Testing should also be considered if an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a family member with Wilms tumor. Molecular genetic testing can include <b>single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b>, <b>gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a></b>, <b><a class="def" href="/books/n/gene/glossary/def-item/methylation/">methylation</a> studies</b>, use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>, and <b><a class="def" href="/books/n/gene/glossary/def-item/chromosomal-microarray/">chromosomal microarray</a> (CMA)</b>. The choice of test should be based on the clinical features.</p><div id="wilms-ov.Individuals_with_Wilms_Tumor_Wi"><h4>Individuals with Wilms Tumor Without Syndromic Features</h4><p><b><i>WT1</i>.</b> Sequence analysis of <i>WT1</i> is performed first. Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> may be performed to detect intragenic deletions.</p><p><b>11p15.5</b>. Methylation studies of 11p15.5 <a class="def" href="/books/n/gene/glossary/def-item/imprinting/">imprinting</a> center 1 (IC1) can be performed if a <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> <i>WT1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is not identified. Of note, in individuals with <a href="/books/n/gene/bws/">Beckwith-Wiedemann syndrome</a> (BWS) and Wilms tumor, only IC1 (IGF2/H19 genes), not IC2, alterations have been observed [<a class="bk_pop" href="#wilms-ov.REF.rump.2005.95">Rump et al 2005</a>, <a class="bk_pop" href="#wilms-ov.REF.weksberg.2010.8">Weksberg et al 2010</a>].</p><p>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a> that includes <i>WT1, REST, DICER1</i> and other genes of interest (see <a class="figpopup" href="/books/NBK1294/table/wilms-ov.T.less_common_causes_of_wilms_t/?report=objectonly" target="object" rid-figpopup="figwilmsovTlesscommoncausesofwilmst" rid-ob="figobwilmsovTlesscommoncausesofwilmst">Table 1</a>) may also be considered. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>; thus, clinicians need to determine which multigene panel is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests. (5) Multigene panels may not include DNA <a class="def" href="/books/n/gene/glossary/def-item/methylation-analysis/">methylation analysis</a> used to detect 11p15.5 alterations.</p><p>For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</p></div><div id="wilms-ov.Individuals_with_Wilms_Tumor_an"><h4>Individuals with Wilms Tumor and Genitourinary Anomalies or Renal Failure</h4><p><b><i>WT1.</i></b> Sequence analysis of <i>WT1</i> is performed first and followed by <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> of <i>WT1</i> if a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is not identified.</p></div><div id="wilms-ov.Individuals_with_Wilms_Tumor_an_1"><h4>Individuals with Wilms Tumor and Physical Features of BWS</h4><p><b>11p15.5.</b> Methylation studies of 11p15.5 IC1 should be performed first in individuals with features of BWS. (See <a href="/books/n/gene/bws/">Beckwith-Wiedemann Syndrome</a> for additional testing issues.)</p></div><div id="wilms-ov.Individuals_with_Wilms_Tumor_an_2"><h4>Individuals with Wilms Tumor and Aniridia</h4><p>Chromosomal microarray (CMA) should be performed first in individuals with suspected WAGR (<i>W</i>ilms tumor, <i>a</i>niridia, <i>g</i>enital anomalies, <i>r</i>etardation). CMA can detect 11p13 deletions encompassing <i>WT1</i> and <i>PAX6</i> as well as provide detailed information regarding size of the <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a>. CMA also gives information regarding deletions and duplications in the remainder of the genome. CMA-<a class="def" href="/books/n/gene/glossary/def-item/snp-array/">SNP array</a> will allow detection of <a class="def" href="/books/n/gene/glossary/def-item/uniparental-disomy/">uniparental disomy</a> at 11p15.5 in cases with long stretches of homozygosity.</p></div></div></div><div id="wilms-ov.Genetic_Counseling"><h2 id="_wilms-ov_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><p>Individuals with Wilms tumor who have features suggestive of a genetic predisposition (bilateral or multifocal Wilms tumor, <a class="def" href="/books/n/gene/glossary/def-item/syndromic/">syndromic</a> features or <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> anomalies associated with Wilms tumor, or family history of Wilms tumor) should receive <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a>. Individuals with unilateral Wilms tumor with no features to suggest a genetic predisposition do not require molecular testing or genetic counseling. No Wilms tumor was observed in the 179 offspring of 96 long-term survivors who had been diagnosed with unilateral, non-<a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> Wilms tumor [<a class="bk_pop" href="#wilms-ov.REF.li.1988.147">Li et al 1988</a>].</p><p><b>Syndromic Wilms tumor</b></p><ul><li class="half_rhythm"><div>If a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> has <a class="def" href="/books/n/gene/glossary/def-item/syndromic/">syndromic</a> Wilms tumor (e.g., <a href="/books/n/gene/aniridia/">WAGR</a>, <a href="/books/n/gene/bws/">Beckwith-Wiedemann syndrome</a>, features suggestive of a syndrome listed in <a class="figpopup" href="/books/NBK1294/table/wilms-ov.T.less_common_causes_of_wilms_t/?report=objectonly" target="object" rid-figpopup="figwilmsovTlesscommoncausesofwilmst" rid-ob="figobwilmsovTlesscommoncausesofwilmst">Table 1</a>), <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> for the specific syndrome is appropriate.</div></li></ul><p><b>Nonsyndromic Wilms tumor associated with a <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> <i>WT1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a></b></p><ul><li class="half_rhythm"><div><b>Mode of inheritance.</b>
<i>WT1</i> <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> variants are inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner with <a class="def" href="/books/n/gene/glossary/def-item/variable-expressivity/">variable expressivity</a> and reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> [<a class="bk_pop" href="#wilms-ov.REF.zirn.2005.1100">Zirn et al 2005</a>].</div></li><li class="half_rhythm"><div><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> In the majority of individuals with a <i>WT1</i> <a class="def" href="/books/n/gene/glossary/def-item/germline-variant/">germline variant</a>, the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> occurred <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a>; parents are unlikely to have had Wilms tumor or to have the germline <i>WT1</i> variant.</div></li><li class="half_rhythm"><div><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> When the <i>WT1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> identified in the proband cannot be detected in the DNA of either parent, the risk to the sibs of a proband is likely to be low; however, the rate of parental <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> is unknown [<a class="bk_pop" href="#wilms-ov.REF.huff.1994.13">Huff 1994</a>].</div></li><li class="half_rhythm"><div><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b> are at a 50% risk of inheriting the <i>WT1</i> <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. The risk of Wilms tumor developing in a child with a known <i>WT1</i> <a class="def" href="/books/n/gene/glossary/def-item/germline-variant/">germline variant</a> depends on the <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> of the specific variant.</div></li></ul><p><b>Nonsyndromic Wilms tumor not associated with a <i>WT1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a></b></p><ul><li class="half_rhythm"><div><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Most individuals diagnosed with nonsyndromic Wilms tumor do not have an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent, but some may have another affected family member (i.e., <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> Wilms tumor).</div></li><li class="half_rhythm"><div><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></div><ul><li class="half_rhythm"><div><b>Simplex case.</b> Empiric risks to the sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> who is the only <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member are unknown but likely low.</div></li><li class="half_rhythm"><div><b>Familial case.</b> Empiric risks to the sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> who does not have an identified <i>WT1</i> <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> of developing Wilms tumor are unknown. In most cases, the genetic variant underlying the risk of Wilms tumor will be unknown, but several genes other than <i>WT1</i> (e.g., <i>REST</i>, <i>CTR9</i> and <i>BRCA2</i>) have been associated with <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> Wilms tumor. The risk to a sib depends on the variant involved.</div></li></ul></li><li class="half_rhythm"><div><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></div><ul><li class="half_rhythm"><div><b>Simplex case.</b> Empiric risks to the offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> who is the only <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member are unknown but likely low.</div></li><li class="half_rhythm"><div><b>Familial case.</b> Empiric risks to the offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with another <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member are estimated to be high, based on the assumption of inheritance of a dominantly acting <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> with incomplete <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a>.</div></li></ul></li></ul><p><b>Bilateral or multifocal nonsyndromic Wilms tumor</b></p><ul><li class="half_rhythm"><div>The presence of bilateral or multifocal disease in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> implies that the proband has a genetic predisposition. However, the majority of individuals with bilateral Wilms tumor have neither a <i>WT1</i> <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> (16% have a <i>WT1</i> germline pathogenic variant) nor an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member (3% have affected family members).</div></li><li class="half_rhythm"><div>The risk to offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with bilateral or multifocal disease is estimated to be high, but the risk varies with the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> in which the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> occurred. Ultrasound screening of the offspring for Wilms tumor in childhood should be considered.</div></li></ul><div id="wilms-ov.Related_Genetic_Counseling_Issu"><h3>Related Genetic Counseling Issues</h3><p>See Management, <a href="#wilms-ov.Surveillance_for_Relatives_at_R">Surveillance for Relatives at Risk for Wilms Tumor Predisposition</a> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p><p><b>Genetic cancer risk assessment and counseling.</b> For a comprehensive description of the medical, psychosocial, and ethical ramifications of identifying at-risk individuals through cancer risk assessment with or without <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>, see <a href="http://www.cancer.gov/about-cancer/causes-prevention/genetics/risk-assessment-pdq" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Cancer Genetics Risk Assessment and Counseling &#x02013; for health professionals</a> (part of PDQ<sup>&#x000ae;</sup>, National Cancer Institute).</p><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="wilms-ov.Prenatal_Testing_and_Preimplant"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once a causative genetic alteration (e.g., <i>WT1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, alteration of 11p15.5, <i>DICER1</i>, or <i>REST</i> pathogenic variant) has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible.</p></div></div><div id="wilms-ov.Resources"><h2 id="_wilms-ov_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>International WAGR Syndrome Association</b></div><div><b>Email:</b> Reachingout@wagr.org</div><div><a href="http://www.wagr.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.wagr.org/</a></div></li><li class="half_rhythm"><div><b>My46 Trait Profile</b></div><div><a href="https://www.my46.org/trait-document?trait=WT1-related%20Wilms%20tumor&#x00026;parent=Genetic%20Syndromes&#x00026;type=profile" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">WT1-Related Wilms Tumor</a></div></li></ul></div><div id="wilms-ov.Management"><h2 id="_wilms-ov_Management_">Management</h2><div id="wilms-ov.Surveillance_of_Children_with_a"><h3>Surveillance of Children with a Germline Pathogenic Variant or with Wilms Tumor-Associated Syndromes</h3><p><b>General considerations.</b> The goal of surveillance in individuals with a genetic predisposition to Wilms tumor is to detect tumors while they are low-stage and require less treatment compared to advanced-stage tumors. Surveillance is not a one-time event and should continue through the period of risk, estimated to be until age five to eight years, depending on the underlying genetic condition. Wilms tumors can double in size every week [<a class="bk_pop" href="#wilms-ov.REF.beckwith.1998a.377">Beckwith 1998a</a>], leading to the authors&#x02019; recommendation that evaluation with abdominal ultrasound be performed every three months. Because surveillance is associated with economic and psychosocial costs including missed work, anxiety associated with exams, and false-positive results leading to unnecessary interventions, the decision to pursue surveillance requires careful consideration. Weighing the risks and benefits of surveillance, <a class="bk_pop" href="#wilms-ov.REF.scott.2006.995">Scott et al [2006]</a> suggested that surveillance be pursued if the risk for tumor development is greater than 5%.</p><p><b>Individuals with a <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> <i>WT1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</b> Screening by abdominal ultrasound examination is recommended every three months until age five years. Among individuals with Wilms tumor and WAGR syndrome, 90% develop a tumor by age four years and 98% by age seven years [<a class="bk_pop" href="#wilms-ov.REF.beckwith.1998b.268">Beckwith 1998b</a>].</p><p><b>Individuals with an 11p15.5 alteration,</b>
<a href="/books/n/gene/bws/"><b>Beckwith-Wiedemann syndrome</b></a>
<b>(BWS), or <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> hemihyperplasia</b> have a 5% to 7.5% risk of developing Wilms tumor or other malignancies (mainly hepatoblastoma, adrenocortical carcinoma, neuroblastoma, and rhabdomyosarcoma). However, risk of Wilms tumor is restricted to certain subtypes of BWS.</p><p>A meta-analysis by <a class="bk_pop" href="#wilms-ov.REF.rump.2005.95">Rump et al [2005]</a> of more than 400 individuals with BWS for whom molecular data at 11p15 were available indicated that:</p><ul><li class="half_rhythm"><div>Wilms tumor was not observed in children with:</div><ul><li class="half_rhythm"><div>Loss of <a class="def" href="/books/n/gene/glossary/def-item/methylation/">methylation</a> at <a class="def" href="/books/n/gene/glossary/def-item/imprinting/">imprinting</a> center 2 (&#x0223c;45% of BWS);</div></li><li class="half_rhythm"><div><i>CDKN1C</i> pathogenic variants (&#x0223c;5-10% of BWS).</div></li></ul></li><li class="half_rhythm"><div>Wilms tumor was observed in children with:</div><ul><li class="half_rhythm"><div>Uniparental isodisomy at 11p15 (&#x0223c;20% of BWS);</div></li><li class="half_rhythm"><div>Gain of <a class="def" href="/books/n/gene/glossary/def-item/methylation/">methylation</a> at <a class="def" href="/books/n/gene/glossary/def-item/imprinting/">imprinting</a> center 1 (&#x0223c;10% of BWS);</div></li><li class="half_rhythm"><div>No detectable <a class="def" href="/books/n/gene/glossary/def-item/methylation/">methylation</a> changes in either <a class="def" href="/books/n/gene/glossary/def-item/imprinting/">imprinting</a> centers 1 or 2 (&#x0223c;25% of BWS).</div></li></ul></li></ul><p>Hence, surveillance may be restricted to individuals with uniparental isodisomy at 11p15, gain of <a class="def" href="/books/n/gene/glossary/def-item/methylation/">methylation</a> at <a class="def" href="/books/n/gene/glossary/def-item/imprinting/">imprinting</a> center 1, or BWS in whom a genetic or epigenetic abnormality is not found. Children with <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> methylation changes of imprinting center 2 or a <i>CDKN1C</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> do not require surveillance for Wilms tumor. When surveillance is pursued, abdominal ultrasound examination is recommended every three months until age eight years. Among individuals with BWS and Wilms tumor, 81% develop the tumor by age five years and 93% develop the tumor by age eight years [<a class="bk_pop" href="#wilms-ov.REF.beckwith.1998a.377">Beckwith 1998a</a>].</p><p><b>Individuals with one of the less common causes of Wilms tumor predisposition.</b> The authors recommend surveillance if the estimated risk for Wilms tumor associated with the genetic variant exceeds 5%. The recommendation can be adjusted depending on the individual preference of the family and treating physician. If the risk period has not been established, surveillance with abdominal ultrasound is recommended every three months until age eight years.</p><p><b>Individuals with bilateral or multifocal Wilms tumor without an identified molecular cause.</b> After completion of therapy for Wilms tumor, individuals should be screened by renal ultrasound examination every three months until age eight years for metachronous tumors. It is assumed that most individuals with bilateral Wilms tumor have a <a class="def" href="/books/n/gene/glossary/def-item/germline-variant/">germline variant</a> in a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> predisposing to Wilms tumor, increasing the risk for a metachronous tumor.</p></div><div id="wilms-ov.Surveillance_for_Relatives_at_R"><h3>Surveillance for Relatives at Risk for Wilms Tumor Predisposition</h3><p>In families with more than one individual with Wilms tumor and families with one individual with bilateral or multifocal Wilms tumor, it is appropriate to evaluate relatives at risk in order to identify as early as possible those who would benefit from prompt initiation of treatment and preventive measures. Evaluations can include the following:</p><ul><li class="half_rhythm"><div>Molecular genetic testing if the causative genetic alteration has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family. Surveillance with ultrasound may be pursued if the Wilms tumor risk associated with the causative variant is sufficiently high.</div></li><li class="half_rhythm"><div>If the causative genetic alteration has not been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member:</div><ul><li class="half_rhythm"><div class="half_rhythm">Offspring of the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual should be screened with abdominal ultrasound examination every three months until age eight years.</div><div class="half_rhythm">Note: The risk for Wilms tumor in the children of survivors of bilateral Wilms tumor is unknown.</div></li><li class="half_rhythm"><div class="half_rhythm">The benefit of surveillance of sibs of the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual is unclear. Only 3% of individuals with bilateral Wilms tumor had an affected family member, indicating that the risk to a sib is even lower than 3%. Surveillance of sibs would not be recommended if applying the threshold risk of tumor greater than 5% as an indication for surveillance.</div></li></ul></li></ul></div></div><div id="wilms-ov.References"><h2 id="_wilms-ov_References_">References</h2><div id="wilms-ov.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="wilms-ov.REF.astuti.2012.277">Astuti D, Morris MR, Cooper WN, Staals RH, Wake NC, Fews GA, Gill H, Gentle D, Shuib S, Ricketts CJ, Cole T, van Essen AJ, van Lingen RA, Neri G, Opitz JM, Rump P, Stolte-Dijkstra I, M&#x000fc;ller F, Pruijn GJ, Latif F, Maher ER. Germline mutations in DIS3L2 cause the Perlman syndrome of overgrowth and Wilms tumor susceptibility. <span><span class="ref-journal">Nat Genet. </span>2012;<span class="ref-vol">44</span>:277–84.</span> [<a href="/pubmed/22306653" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22306653</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="wilms-ov.REF.barbaux.1997.467">Barbaux S, Niaudet P, Gubler MC, Grunfeld JP, Jaubert F, Kuttenn F, Fekete CN, Souleyreau-Therville N, Thibaud E, Fellous M, McElreavey K. Donor splice-site mutations in WT1 are responsible for Frasier syndrome. <span><span class="ref-journal">Nat Genet. </span>1997;<span class="ref-vol">17</span>:467–70.</span> [<a href="/pubmed/9398852" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9398852</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="wilms-ov.REF.beckwith.1998a.377">Beckwith JB. Children at increased risk for Wilms tumor: monitoring issues. <span><span class="ref-journal">J Pediatr. </span>1998a;<span class="ref-vol">132</span>:377–9.</span> [<a href="/pubmed/9544882" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9544882</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="wilms-ov.REF.beckwith.1998b.268">Beckwith JB. Nephrogenic rests and the pathogenesis of Wilms tumor: developmental and clinical considerations. <span><span class="ref-journal">Am J Med Genet. </span>1998b;<span class="ref-vol">79</span>:268–73.</span> [<a href="/pubmed/9781906" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9781906</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="wilms-ov.REF.beckwith.1993.158">Beckwith JB. Precursor lesions of Wilms tumor: clinical and biological implications. <span><span class="ref-journal">Med Pediatr Oncol. </span>1993;<span class="ref-vol">21</span>:158–68.</span> [<a href="/pubmed/8383276" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8383276</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="wilms-ov.REF.birch.2001.4621">Birch JM, Alston RD, McNally RJQ, Evans DGR, Kelsey AM, Harris M, Eden OB, Varley JM. Relative frequency and morphology of cancers in carriers of germline TP53 mutations. <span><span class="ref-journal">Oncogene. </span>2001;<span class="ref-vol">20</span>:4621–8.</span> [<a href="/pubmed/11498785" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11498785</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="wilms-ov.REF.breslow.2005.1972">Breslow NE, Collins AJ, Ritchey ML, Grigoriev YA, Peterson SM, Green DM. End stage renal disease in patients with Wilms tumor: results from the National Wilms Tumor Study Group and the United States Renal Data System. <span><span class="ref-journal">J Urol. </span>2005;<span class="ref-vol">174</span>:1972–5.</span> [<a href="/pmc/articles/PMC1483840/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1483840</span></a>] [<a href="/pubmed/16217371" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16217371</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="wilms-ov.REF.breslow.2003.4579">Breslow NE, Norris R, Norkool PA, Kang T, Beckwith JB, Perlman EJ, Ritchey ML, Green DM, Nichols KE. Characteristics and outcomes of children with the Wilms tumor-Aniridia syndrome: a report from the National Wilms Tumor Study Group. <span><span class="ref-journal">J Clin Oncol. </span>2003;<span class="ref-vol">21</span>:4579–85.</span> [<a href="/pubmed/14673045" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14673045</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="wilms-ov.REF.breslow.2000.4030">Breslow NE, Takashima JR, Ritchey ML, Strong LC, Green DM. Renal failure in the Denys-Drash and Wilms' tumor-aniridia syndromes. <span><span class="ref-journal">Cancer Res. </span>2000;<span class="ref-vol">60</span>:4030–2.</span> [<a href="/pubmed/10945603" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10945603</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="wilms-ov.REF.callier.2005.204">Callier P, Faivre L, Cusin V, Marle N, Thauvin-Robinet C, Sandre D, Rousseau T, Sagot P, Lacombe E, Faber V, Mugneret F. Microcephaly is not mandatory for the diagnosis of mosaic variegated aneuploidy syndrome. <span><span class="ref-journal">Am J Med Genet A. </span>2005;<span class="ref-vol">137</span>:204–7.</span> [<a href="/pubmed/16059936" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16059936</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="wilms-ov.REF.diller.1998.3634">Diller L, Ghahremani M, Morgan J, Grundy P, Reeves C, Breslow N, Green D, Neuberg D, Pelletier J, Li FP. Constitutional WT1 mutations in Wilms' tumor patients. <span><span class="ref-journal">J Clin Oncol. </span>1998;<span class="ref-vol">16</span>:3634–40.</span> [<a href="/pubmed/9817285" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9817285</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="wilms-ov.REF.dome.2002.5">Dome JS, Coppes MJ. Recent advances in Wilms tumor genetics. <span><span class="ref-journal">Curr Opin Pediatr. </span>2002;<span class="ref-vol">14</span>:5–11.</span> [<a href="/pubmed/11880727" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11880727</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="wilms-ov.REF.eddy.1985.584">Eddy AA, Mauer SM. Pseudohermaphroditism, glomerulopathy, and Wilms tumor (Drash syndrome): frequency in end-stage renal failure. <span><span class="ref-journal">J Pediatr. </span>1985;<span class="ref-vol">106</span>:584–7.</span> [<a href="/pubmed/2984395" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 2984395</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="wilms-ov.REF.finken.2015.211">Finken MJ, Hendriks YM, van der Voorn JP, Veening MA, Lombardi MP, Rotteveel J. WT1 deletion leading to severe 46,XY gonadal dysgenesis, Wilms tumor and gonadoblastoma: case report. <span><span class="ref-journal">Horm Res Paediatr. </span>2015;<span class="ref-vol">83</span>:211–6.</span> [<a href="/pubmed/25613702" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25613702</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="wilms-ov.REF.fischbach.2005.984">Fischbach BV, Trout KL, Lewis J. Kyus CAm Sika M. WAGR Syndrome: A clinical review of 54 cases. <span><span class="ref-journal">Pediatrics. </span>2005;<span class="ref-vol">116</span>:984–8.</span> [<a href="/pubmed/16199712" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16199712</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="wilms-ov.REF.foulkes.2011.1381">Foulkes WD, Bahubeshi A, Hamel N, Pasini B, Asioli S, Baynam G, Choong CS, Charles A, Frieder RP, Dishop MK, Graf N, Ekim M, Bouron-Dal Soglio D, Arseneau J, Young RH, Sabbaghian N, Srivastava A, Tischkowitz MD, Priest JR. Extending the phenotypes associated with DICER1 mutations. <span><span class="ref-journal">Hum Mutat. </span>2011;<span class="ref-vol">32</span>:1381–4.</span> [<a href="/pubmed/21882293" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21882293</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="wilms-ov.REF.garc_acastillo.2008.1687">Garc&#x000ed;a-Castillo H, V&#x000e1;squez-Vel&#x000e1;squez AI, Rivera H, Barros-N&#x000fa;&#x000f1;ez P. Clinical and genetic heterogeneity in patients with mosaic variegated aneuploidy: delineation of clinical subtypes. <span><span class="ref-journal">Am J Med Genet A. </span>2008;<span class="ref-vol">146A</span>:1687–95.</span> [<a href="/pubmed/18548531" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18548531</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="wilms-ov.REF.gripp.2016.2559">Gripp KW, Baker L, Kandula V, Conard K, Scavina M, Napoli JA, Griffin GC, Thacker M, Knox RG, Clark GR, Parker VE, Semple R, Mirzaa G, Keppler-Noreuil KM. Nephroblastomatosis or Wilms tumor in a fourth patient with a somatic PIK3CA mutation. <span><span class="ref-journal">Am J Med Genet A. </span>2016;<span class="ref-vol">170</span>:2559–69.</span> [<a href="/pmc/articles/PMC5514817/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5514817</span></a>] [<a href="/pubmed/27191687" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27191687</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="wilms-ov.REF.gr_nskov.2001.11">Gr&#x000f8;nskov K, Olsen J, Sand A, Pedersen W, Carlsen N, Bak Jylling AM, Lyngbye T, Br&#x000f8;ndum-Nielsen K, Rosenberg T. Population-based risk estimates of Wilms tumor in sporadic aniridia. A comprehensive mutation screening procedure of PAX6 identifies 80% of mutations in aniridia. <span><span class="ref-journal">Hum Genet. </span>2001;<span class="ref-vol">109</span>:11–8.</span> [<a href="/pubmed/11479730" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11479730</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="wilms-ov.REF.grundy.1988.374">Grundy P, Koufos A, Morgan K, Li FP, Meadows AT, Cavenee WK. Familial predisposition to Wilms' tumour does not map to the short arm of chromosome 11. <span><span class="ref-journal">Nature. </span>1988;<span class="ref-vol">336</span>:374–6.</span> [<a href="/pubmed/2848199" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 2848199</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="wilms-ov.REF.hanks.2014.4398">Hanks S, Perdeaux ER, Seal S, Ruark E, Mahamdallie SS, Murray A, Ramsay E, del Vecchio Duarte S, Zachariou A, de Souza B, Warren-Perry M, Elliott A, Davidson A, Price H, Stiller C, Pritchard-Jones K, Rahman N. Germline mutations in the PAF1 complex gene CTR9 predispose to Wilms tumour. <span><span class="ref-journal">Nat Commun. </span>2014;<span class="ref-vol">5</span>:4398.</span> [<a href="/pmc/articles/PMC4143912/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4143912</span></a>] [<a href="/pubmed/25099282" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25099282</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="wilms-ov.REF.huff.1994.13">Huff V. Parental origin of WT1 mutations and mental retardation in WAGR syndrome. <span><span class="ref-journal">Nat Genet. </span>1994;<span class="ref-vol">8</span>:13–4.</span> [<a href="/pubmed/7987386" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7987386</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="wilms-ov.REF.huff.1998.260">Huff V. Wilms tumor genetics. <span><span class="ref-journal">Am J Med Genet. </span>1998;<span class="ref-vol">79</span>:260–7.</span> [<a href="/pubmed/9781905" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9781905</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="wilms-ov.REF.huff.1988.377">Huff V, Compton DA, Chao LY, Strong LC, Geiser CF, Saunders GF. Lack of linkage of familial Wilms' tumour to chromosomal band 11p13. <span><span class="ref-journal">Nature. </span>1988;<span class="ref-vol">336</span>:377–8.</span> [<a href="/pubmed/2848200" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 2848200</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="wilms-ov.REF.kakinuma.1994.123">Kakinuma A, Morimoto I, Nakano Y, Fujimoto R, Ishida O, Okada Y, Inokuchi N, Fujihira T, Eto S. Familial primary hyperparathyroidism complicated with Wilms' tumor. <span><span class="ref-journal">Intern Med. </span>1994;1994;<span class="ref-vol">33</span>:123–6.</span> [<a href="/pubmed/7912571" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7912571</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="wilms-ov.REF.karlberg.2009.570">Karlberg S, Lipsanen-Nyman M, Lassus H, Kallij&#x000e4;rvi J, Lehesjoki AE, Butzow R. Gynecological tumors in Mulibrey nanism and role for RING finger protein TRIM37 in the pathogenesis of ovarian fibrothecomas. <span><span class="ref-journal">Mod Pathol. </span>2009;<span class="ref-vol">22</span>:570–8.</span> [<a href="/pubmed/19329943" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19329943</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="wilms-ov.REF.koziell.2000.519">Koziell A, Charmandari E, Hindmarsh PC, Rees L, Scambler P, Brook CG. Frasier syndrome, part of the Denys Drash continuum or simply a WT1 gene associated disorder of intersex and nephropathy? <span><span class="ref-journal">Clin Endocrinol (Oxf). </span>2000;<span class="ref-vol">52</span>:519–24.</span> [<a href="/pubmed/10762296" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10762296</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="wilms-ov.REF.lapunzina.2005.53">Lapunzina P. Risk of tumorigenesis in overgrowth syndromes: a comprehensive review. <span><span class="ref-journal">Am J Med Genet C Semin Med Genet. </span>2005;<span class="ref-vol">137C</span>:53–71.</span> [<a href="/pubmed/16010678" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16010678</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="wilms-ov.REF.li.1988.147">Li FP, Williams WR, Gimbrere K, Flamant F, Green DM, Meadows AT. Heritable fraction of unilateral Wilms tumor. <span><span class="ref-journal">Pediatrics. </span>1988;<span class="ref-vol">81</span>:147–9.</span> [<a href="/pubmed/2827098" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 2827098</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="wilms-ov.REF.little.2004.4140">Little SE, Hanks SP, King-Underwood L, Jones C, Rapley EA, Rahman N, Pritchard-Jones K. Frequency and heritability of WT1 mutations in nonsyndromic Wilms' tumor patients: a UK Children's Cancer Study Group Study. <span><span class="ref-journal">J Clin Oncol. </span>2004;<span class="ref-vol">22</span>:4140–6.</span> [<a href="/pubmed/15483024" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15483024</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="wilms-ov.REF.mahamdallie.2015.1471">Mahamdallie SS, Hanks S, Karlin KL, Zachariou A, Perdeaux ER, Ruark E, Shaw CA, Renwick A, Ramsay E, Yost S, Elliott A, Birch J, Capra M, Gray J, Hale J, Kingston J, Levitt G, McLean T, Sheridan E, Renwick A, Seal S, Stiller C, Sebire N, Westbrook TF, Rahman N. Mutations in the transcriptional repressor REST predispose to Wilms tumor. <span><span class="ref-journal">Nat Genet. </span>2015;<span class="ref-vol">47</span>:1471–4.</span> [<a href="/pubmed/26551668" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26551668</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="wilms-ov.REF.moreira.2013">Moreira MB, Quaio CRDC, Zandon&#x000e1;-Teixeira AC, Novo-Filho GM, Zanardo EA, Kulikowski LD, and Kim CA. Discrepant outcomes in two Brazilian patients with Bloom syndrome and Wilms&#x02019; tumor: two case reports J Med Case Rep. 2013; 7: 284. [<a href="/pmc/articles/PMC3897898/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3897898</span></a>] [<a href="/pubmed/24377487" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24377487</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="wilms-ov.REF.mueller.1994.471">Mueller RF. The Denys-Drash syndrome. <span><span class="ref-journal">J Med Genet. </span>1994;<span class="ref-vol">31</span>:471–477.</span> [<a href="/pmc/articles/PMC1049926/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1049926</span></a>] [<a href="/pubmed/8071974" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8071974</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="wilms-ov.REF.muto.2002.285">Muto R, Yamamori S, Ohashi H, Osawa M. Prediction by FISH analysis of the occurrence of Wilms tumor in aniridia patients. <span><span class="ref-journal">Am J Med Genet. </span>2002;<span class="ref-vol">108</span>:285–9.</span> [<a href="/pubmed/11920832" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11920832</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="wilms-ov.REF.olson.1995.305">Olson JM, Hamilton A, Breslow NE. Non-11p constitutional chromosome abnormalities in Wilms' tumor patients. <span><span class="ref-journal">Med Pediatr Oncol. </span>1995;<span class="ref-vol">24</span>:305–9.</span> [<a href="/pubmed/7700182" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7700182</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="wilms-ov.REF.palculict.2016.385">Palculict TB, Ruteshouser EC, Fan Y, Wang W, Strong LC, Huff V. Identification of germline DICER1 mutations and loss of heterozygosity in familial Wilms tumour. <span><span class="ref-journal">J Med Genet. </span>2016;<span class="ref-vol">53</span>:385–8.</span> [<a href="/pmc/articles/PMC4866907/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4866907</span></a>] [<a href="/pubmed/26566882" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26566882</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="wilms-ov.REF.reid.2005.147">Reid S, Renwick A, Seal S, Baskcomb L, Barfoot R, Jayatilake H, Pritchard-Jones K, Stratton MR, Ridolfi-Luthy A, Rahman N. Biallelic BRCA2 mutations are associated with multiple malignancies in childhood including familial Wilms tumour. <span><span class="ref-journal">J Med Genet. </span>2005;<span class="ref-vol">42</span>:147–51.</span> [<a href="/pmc/articles/PMC1735989/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1735989</span></a>] [<a href="/pubmed/15689453" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15689453</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="wilms-ov.REF.reid.2007.162">Reid S, Schindler D, Hanenberg H, Barker K, Hanks S, Kalb R, Neveling K, Kelly P, Seal S, Freund M, Wurm M, Batish SD, Lach FP, Yetgin S, Neitzel H, Ariffin H, Tischkowitz M, Mathew CG, Auerbach AD, Rahman N. Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer. <span><span class="ref-journal">Nat Genet. </span>2007;<span class="ref-vol">39</span>:162–4.</span> [<a href="/pubmed/17200671" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17200671</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="wilms-ov.REF.royerpokora.2004.249">Royer-Pokora B, Beier M, Henzler M, Alam R, Schumacher V, Weirich A, Huff V. Twenty-four new cases of WT1 germline mutations and review of the literature: genotype/phenotype correlations for Wilms tumor development. <span><span class="ref-journal">Am J Med Genet A. </span>2004;<span class="ref-vol">127A</span>:249–57.</span> [<a href="/pubmed/15150775" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15150775</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="wilms-ov.REF.rump.2005.95">Rump P, Zeegers MP, van Essen AJ. Tumor risk in Beckwith-Wiedemann syndrome: A review and meta-analysis. <span><span class="ref-journal">Am J Med Genet A. </span>2005;<span class="ref-vol">136</span>:95–104.</span> [<a href="/pubmed/15887271" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15887271</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="wilms-ov.REF.schlegelberger.2015.1481">Schlegelberger B, Kreipe H, Lehmann U, Steinemann D, Ripperger T, G&#x000f6;hring G, Thomay K, Rump A, Di Donato N, Suttorp M. A child with Li-Fraumeni syndrome: Modes to inactivate the second allele of TP53 in three different malignancies. <span><span class="ref-journal">Pediatr Blood Cancer. </span>2015;<span class="ref-vol">62</span>:1481–4.</span> [<a href="/pubmed/25787918" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25787918</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="wilms-ov.REF.scott.2008.1329">Scott RH, Douglas J, Baskcomb L, Huxter N, Barker K, Hanks S, Craft A, Gerrard M, Kohler JA, Levitt GA, Picton S, Pizer B, Ronghe MD, Williams D., Factors Associated with Childhood Tumours (FACT) Collaboration.  Cook JA, Pujol P, Maher ER, Birch JM, Stiller CA, Pritchard-Jones K, Rahman N. Constitutional 11p15 abnormalities, including heritable imprinting center mutations, cause nonsyndromic Wilms tumor. <span><span class="ref-journal">Nat Genet. </span>2008;<span class="ref-vol">40</span>:1329–34.</span> [<a href="/pubmed/18836444" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18836444</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="wilms-ov.REF.scott.2006.995">Scott RH, Walker L, Olsen &#x000d8;E, Levitt G, Kenney I, Maher E, Owens CM, Pritchard-Jones K, Craft A, Rahman N. Surveillance for Wilms tumour in at-risk children: pragmatic recommendations for best practice. <span><span class="ref-journal">Arch Dis Child. </span>2006;<span class="ref-vol">91</span>:995–9.</span> [<a href="/pmc/articles/PMC2083016/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2083016</span></a>] [<a href="/pubmed/16857697" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16857697</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="wilms-ov.REF.segers.2012.3249">Segers H, Kersseboom R, Alders M, Pieters R, Wagner A, van den Heuvel-Eibrink MM. Frequency of WT1 and 11p15 constitutional aberrations and phenotypic correlation in childhood Wilms tumour patients. <span><span class="ref-journal">Eur J Cancer. </span>2012;<span class="ref-vol">48</span>:3249–56.</span> [<a href="/pubmed/22796116" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22796116</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="wilms-ov.REF.shanske.2006.966">Shanske AL. Trisomy 18 in a second 20-year-old woman. <span><span class="ref-journal">Am J Med Genet A. </span>2006;<span class="ref-vol">140</span>:966–7.</span> [<a href="/pubmed/16575893" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16575893</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="wilms-ov.REF.sweeney.2000.171">Sweeney H, Pelegano J. Wilms tumor in a child with trisomy 13. <span><span class="ref-journal">J Pediatr Hematol Oncol. </span>2000;<span class="ref-vol">22</span>:171–2.</span> [<a href="/pubmed/10779034" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10779034</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="wilms-ov.REF.szab_.1995.944">Szab&#x000f3; J, Heath B, Hill VM, Jackson CE, Zarbo RJ, Mallette LE, Chew SL, Besser GM, Thakker RV, Huff V, Leppert MF, Heath H. Hereditary hyperparathyroidism-jaw tumor syndrome: the endocrine tumor gene HRPT2 maps to chromosome 1q21-q31. <span><span class="ref-journal">Am J Hum Genet. </span>1995;<span class="ref-vol">56</span>:944–50.</span> [<a href="/pmc/articles/PMC1801214/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1801214</span></a>] [<a href="/pubmed/7717405" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7717405</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="wilms-ov.REF.weksberg.2010.8">Weksberg R, Shuman C, Beckwith JB. Beckwith-Wiedemann syndrome. <span><span class="ref-journal">Eur J Hum Genet. </span>2010;<span class="ref-vol">18</span>:8–14.</span> [<a href="/pmc/articles/PMC2987155/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2987155</span></a>] [<a href="/pubmed/19550435" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19550435</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="wilms-ov.REF.zirn.2005.1100">Zirn B, Wittmann S, Gessler M. Novel familial WT1 read-through mutation associated with Wilms tumor and slow progressive nephropathy. <span><span class="ref-journal">Am J Kidney Dis. </span>2005;<span class="ref-vol">45</span>:1100–4.</span> [<a href="/pubmed/15957141" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15957141</span></a>]</div></li></ul></div></div><div id="wilms-ov.Chapter_Notes"><h2 id="_wilms-ov_Chapter_Notes_">Chapter Notes</h2><div id="wilms-ov.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>20 October 2016 (sw) Comprehensive update posted live</div></li><li class="half_rhythm"><div>19 September 2013 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>14 June 2011 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>10 April 2006 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>24 May 2004 (cd) Revision: Genetic Counseling</div></li><li class="half_rhythm"><div>19 December 2003 (me) Overview posted live</div></li><li class="half_rhythm"><div>14 July 2003 (jsd) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK1294</span><span class="label">PMID: <a href="/pubmed/20301471" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301471</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/williams/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/wilson/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK1294&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK1294/?report=reader">PubReader</a></li><li><a href="/books/NBK1294/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK1294" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK1294" style="display:none" title="Cite this Page"><div class="bk_tt">Dome JS, Huff V. Wilms Tumor Predisposition. 2003 Dec 19 [Updated 2016 Oct 20]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK1294/pdf/Bookshelf_NBK1294.pdf">PDF version of this page</a> (429K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#wilms-ov.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#wilms-ov.Clinical_Characteristics_of_Wil" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics of Wilms Tumor</a></li><li><a href="#wilms-ov.Mechanisms_of_Predisposition_to" ref="log$=inpage&amp;link_id=inpage">Mechanisms of Predisposition to Wilms Tumor</a></li><li><a href="#wilms-ov.Evaluation_Strategy" ref="log$=inpage&amp;link_id=inpage">Evaluation Strategy</a></li><li><a href="#wilms-ov.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#wilms-ov.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#wilms-ov.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#wilms-ov.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#wilms-ov.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=64324[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">NSD1</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=675[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">BRCA2</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=1028[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">CDKN1C</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=4763[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">NF1</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=2719[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">GPC3</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=2239[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">GPC4</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=283120[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">H19</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=7157[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">TP53</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=7490[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">WT1</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=3784[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">KCNQ1</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=641[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">BLM</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=79577[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">CDC73</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=10984[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">KCNQ1OT1</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=3481[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">IGF2</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=129563[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">DIS3L2</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1498810" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1498810" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20054657" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedarticles&amp;logdbfrom=pubmed">A new familial cancer syndrome including predisposition to Wilms tumor and neuroblastoma.</a><span class="source">[Fam Cancer. 2010]</span><div class="brieflinkpop offscreen_noflow">A new familial cancer syndrome including predisposition to Wilms tumor and neuroblastoma.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Abbaszadeh F, Barker KT, McConville C, Scott RH, Rahman N. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Fam Cancer. 2010 Sep; 9(3):425-30. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/12692171" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedarticles&amp;logdbfrom=pubmed">American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.</a><span class="source">[J Clin Oncol. 2003]</span><div class="brieflinkpop offscreen_noflow">American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">American Society of Clinical Oncology.. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">J Clin Oncol. 2003 Jun 15; 21(12):2397-406. Epub 2003 Apr 11.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/8591963" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Screening for Wilms tumor in high-risk individuals.</a><span class="source">[Hematol Oncol Clin North Am. 1...]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Screening for Wilms tumor in high-risk individuals.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Clericuzio CL, Johnson C. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Hematol Oncol Clin North Am. 1995 Dec; 9(6):1253-65. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/15750927" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Decreased E-cadherin expression correlates with higher stage of Wilms' tumors.</a><span class="source">[J Pediatr Surg. 2005]</span><div class="brieflinkpop offscreen_noflow">Decreased E-cadherin expression correlates with higher stage of Wilms' tumors.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Safford SD, Freemerman AJ, Langdon S, Bentley R, Goyeau D, Grundy PE, Skinner MA. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">J Pediatr Surg. 2005 Feb; 40(2):341-8. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/8827068" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Screening for Wilms' tumor in children with high-risk congenital syndromes: considerations for an intervention trial.</a><span class="source">[Med Pediatr Oncol. 1996]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Screening for Wilms' tumor in children with high-risk congenital syndromes: considerations for an intervention trial.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">DeBaun MR, Brown M, Kessler L. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Med Pediatr Oncol. 1996 Nov; 27(5):415-21. </em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301471" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301471" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e0411d375f66d18aae963a9">Wilms Tumor Predisposition - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Wilms Tumor Predisposition - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T20:50:11-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal102&amp;ncbi_phid=CE898649E04102010000000000E20061&amp;ncbi_session=CE898649E0411D21_0226SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK1294%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK1294&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK1294/&amp;ncbi_pagename=Wilms Tumor Predisposition - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE898649E0411D21_0226SID /projects/books/PBooks@5.22 portal102 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>